Multiple mechanisms of serotonergic signal transduction
- PMID: 2441225
- DOI: 10.1016/0024-3205(87)90621-7
Multiple mechanisms of serotonergic signal transduction
Abstract
In this article we review serotonergic signal transduction mechanisms in the central and peripheral nervous systems and in a variety of target organs. The various classes of pharmacologically defined serotonergic receptors are coupled to three major effector systems: (1) adenylate cyclase; (2) phospholipase C mediated phosphoinositide (PI) hydrolysis and (3) ion channels (K+ and Ca++). Long term occupancy of serotonergic receptors also appears to induce alterations in mRNA and protein synthesis. For all three types of signal transduction there is evidence accumulating which suggests the involvement of guanine nucleotide regulatory proteins. Recent findings suggest that the distinct types of pharmacologically defined serotonergic receptors (5HT1A, 5HT1B, 5HT1c, 5HT2) may be coupled to one or more signal transduction systems. Thus, 5HT1 receptors may both activate and inhibit adenylate cyclase and increase K+-ion conductance in the hippocampus. 5HT2 receptors which activate PI hydrolysis in the brain, both open voltage-gated calcium channels and activate PI metabolism in certain smooth muscle preparations. Thus, each class of serotonergic receptor may be linked to one or more distinct biochemical transduction mechanisms. The possibility is raised that selective agonists and antagonists might be developed which have specific effects on a particular receptor-linked effector system.
Similar articles
-
Pharmacology of serotonin as related to anesthesia.J Clin Anesth. 1996 Aug;8(5):402-25. doi: 10.1016/0952-8180(96)00093-1. J Clin Anesth. 1996. PMID: 8832453 Review.
-
Central serotonin receptors: effector systems, physiological roles and regulation.Psychopharmacology (Berl). 1987;92(3):267-77. doi: 10.1007/BF00210830. Psychopharmacology (Berl). 1987. PMID: 2819915
-
Receptors and phosphoinositide metabolism in the central nervous system.Biochem Pharmacol. 1986 Aug 1;35(15):2447-53. doi: 10.1016/0006-2952(86)90038-9. Biochem Pharmacol. 1986. PMID: 2427081 Review. No abstract available.
-
Inhibitors of serotonin synthesis and antagonists of serotonin 1A receptors inhibit T lymphocyte function in vitro and cell-mediated immunity in vivo.J Immunol. 1994 Jul 15;153(2):489-98. J Immunol. 1994. PMID: 8021490
-
Presynaptic serotonergic inhibition of GABAergic synaptic transmission in mechanically dissociated rat basolateral amygdala neurons.J Physiol. 1999 Jul 15;518 ( Pt 2)(Pt 2):525-38. doi: 10.1111/j.1469-7793.1999.0525p.x. J Physiol. 1999. PMID: 10381597 Free PMC article.
Cited by
-
Drugs and receptors. An overview of the current state of knowledge.Drugs. 1990 Nov;40(5):666-87. doi: 10.2165/00003495-199040050-00003. Drugs. 1990. PMID: 2292230 Review.
-
Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery.Pharmacol Rev. 2010 Jun;62(2):265-304. doi: 10.1124/pr.108.000992. Epub 2010 Apr 14. Pharmacol Rev. 2010. PMID: 20392808 Free PMC article. Review.
-
Signalling bias in new drug discovery: detection, quantification and therapeutic impact.Nat Rev Drug Discov. 2013 Mar;12(3):205-16. doi: 10.1038/nrd3954. Epub 2012 Feb 15. Nat Rev Drug Discov. 2013. PMID: 23411724 Review.
-
Structure-Activity Assessment and In-Depth Analysis of Biased Agonism in a Set of Phenylalkylamine 5-HT2A Receptor Agonists.ACS Chem Neurosci. 2023 Aug 2;14(15):2727-2742. doi: 10.1021/acschemneuro.3c00267. Epub 2023 Jul 20. ACS Chem Neurosci. 2023. PMID: 37474114 Free PMC article.
-
Biased and g protein-independent signaling of chemokine receptors.Front Immunol. 2014 Jun 23;5:277. doi: 10.3389/fimmu.2014.00277. eCollection 2014. Front Immunol. 2014. PMID: 25002861 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous